Structure of the Malaria Antigen AMA1 in Complex with a Growth-inhibitory Antibody

Overview

Journal PLoS Pathog

Specialty Microbiology

Date 2007 Oct 3

PMID 17907804

Citations 65

Authors

Andrew M Coley

Aditi Gupta

Vince J Murphy

Tao Bai

Hanna Kim

Michael Foley

Robin F Anders

Adrian H Batchelor

Affiliations

Soon will be listed here.

Abstract

Identifying functionally critical regions of the malaria antigen AMA1 (apical membrane antigen 1) is necessary to understand the significance of the polymorphisms within this antigen for vaccine development. The crystal structure of AMA1 in complex with the Fab fragment of inhibitory monoclonal antibody 1F9 reveals that 1F9 binds to the AMA1 solvent-exposed hydrophobic trough, confirming its importance. 1F9 uses the heavy and light chain complementarity-determining regions (CDRs) to wrap around the polymorphic loops adjacent to the trough, but uses a ridge of framework residues to bind to the hydrophobic trough. The resulting 1F9-AMA1-combined buried surface of 2,470 A(2) is considerably larger than previously reported Fab-antigen interfaces. Mutations of polymorphic AMA1 residues within the 1F9 epitope disrupt 1F9 binding and dramatically reduce the binding of affinity-purified human antibodies. Moreover, 1F9 binding to AMA1 is competed by naturally acquired human antibodies, confirming that the 1F9 epitope is a frequent target of immunological attack.

Citing Articles

Potent AMA1-specific human monoclonal antibody against Plasmodium vivax Pre-erythrocytic and Blood Stages.

Winnicki A, Dietrich M, Yeoh L, Carias L, Roobsoong W, Drago C Nat Commun. 2024; 15(1):10556.

PMID: 39632799 PMC: 11618605. DOI: 10.1038/s41467-024-53848-4.

Conformational variability in the D2 loop of Apical Membrane antigen 1.

Saul F, Vulliez-Le Normand B, Boes A, Spiegel H, Kocken C, Faber B J Struct Biol X. 2024; 10:100110.

PMID: 39324028 PMC: 11422552. DOI: 10.1016/j.yjsbx.2024.100110.

A broadly cross-reactive i-body to AMA1 potently inhibits blood and liver stages of Plasmodium parasites.

Angage D, Chmielewski J, Maddumage J, Hesping E, Caiazzo S, Lai K Nat Commun. 2024; 15(1):7206.

PMID: 39174515 PMC: 11341838. DOI: 10.1038/s41467-024-50770-7.

Diversity and selection analyses identify transmission-blocking antigens as the optimal vaccine candidates in Plasmodium falciparum.

Ciubotariu I, Broyles B, Xie S, Thimmapuram J, Mwenda M, Mambwe B EBioMedicine. 2024; 106:105227.

PMID: 39018754 PMC: 11663769. DOI: 10.1016/j.ebiom.2024.105227.

Diversity and selection analyses identify transmission-blocking antigens as the optimal vaccine candidates in .

Ciubotariu I, Broyles B, Xie S, Thimmapuram J, Mwenda M, Mambwe B medRxiv. 2024; .

PMID: 38766239 PMC: 11100930. DOI: 10.1101/2024.05.11.24307175.

References

Alexander D, Arastu-Kapur S, Dubremetz J, Boothroyd J . Plasmodium falciparum AMA1 binds a rhoptry neck protein homologous to TgRON4, a component of the moving junction in Toxoplasma gondii. Eukaryot Cell. 2006; 5(7):1169-73. PMC: 1489286. DOI: 10.1128/EC.00040-06. View

Igonet S, Vulliez-Le Normand B, Faure G, Riottot M, Kocken C, Thomas A . Cross-reactivity studies of an anti-Plasmodium vivax apical membrane antigen 1 monoclonal antibody: binding and structural characterisation. J Mol Biol. 2007; 366(5):1523-37. DOI: 10.1016/j.jmb.2006.12.028. View

Healer J, Crawford S, Ralph S, McFadden G, Cowman A . Independent translocation of two micronemal proteins in developing Plasmodium falciparum merozoites. Infect Immun. 2002; 70(10):5751-8. PMC: 128307. DOI: 10.1128/IAI.70.10.5751-5758.2002. View

Burns Jr J, Flaherty P, Nanavati P, Weidanz W . Protection against Plasmodium chabaudi malaria induced by immunization with apical membrane antigen 1 and merozoite surface protein 1 in the absence of gamma interferon or interleukin-4. Infect Immun. 2004; 72(10):5605-12. PMC: 517570. DOI: 10.1128/IAI.72.10.5605-5612.2004. View

Cortes A, Mellombo M, Masciantonio R, Murphy V, Reeder J, Anders R . Allele specificity of naturally acquired antibody responses against Plasmodium falciparum apical membrane antigen 1. Infect Immun. 2004; 73(1):422-30. PMC: 538974. DOI: 10.1128/IAI.73.1.422-430.2005. View

Escalante A, Grebert H, Chaiyaroj S, Magris M, Biswas S, Nahlen B . Polymorphism in the gene encoding the apical membrane antigen-1 (AMA-1) of Plasmodium falciparum. X. Asembo Bay Cohort Project. Mol Biochem Parasitol. 2001; 113(2):279-87. DOI: 10.1016/s0166-6851(01)00229-8. View

Silvie O, Franetich J, Charrin S, Mueller M, Siau A, Bodescot M . A role for apical membrane antigen 1 during invasion of hepatocytes by Plasmodium falciparum sporozoites. J Biol Chem. 2003; 279(10):9490-6. DOI: 10.1074/jbc.M311331200. View

Baird J . Host age as a determinant of naturally acquired immunity to Plasmodium falciparum. Parasitol Today. 1995; 11(3):105-11. DOI: 10.1016/0169-4758(95)80167-7. View

McCoy A, Grosse-Kunstleve R, Storoni L, Read R . Likelihood-enhanced fast translation functions. Acta Crystallogr D Biol Crystallogr. 2005; 61(Pt 4):458-64. DOI: 10.1107/S0907444905001617. View

10.

Howell S, Kocken C, Thomas A, Blackman M . Proteolytic processing and primary structure of Plasmodium falciparum apical membrane antigen-1. J Biol Chem. 2001; 276(33):31311-20. DOI: 10.1074/jbc.M103076200. View

11.

. The CCP4 suite: programs for protein crystallography. Acta Crystallogr D Biol Crystallogr. 1994; 50(Pt 5):760-3. DOI: 10.1107/S0907444994003112. View

12.

Mitchell G, Thomas A, Margos G, Dluzewski A, Bannister L . Apical membrane antigen 1, a major malaria vaccine candidate, mediates the close attachment of invasive merozoites to host red blood cells. Infect Immun. 2003; 72(1):154-8. PMC: 343990. DOI: 10.1128/IAI.72.1.154-158.2004. View

13.

Healer J, Murphy V, Hodder A, Masciantonio R, Gemmill A, Anders R . Allelic polymorphisms in apical membrane antigen-1 are responsible for evasion of antibody-mediated inhibition in Plasmodium falciparum. Mol Microbiol. 2004; 52(1):159-68. DOI: 10.1111/j.1365-2958.2003.03974.x. View

14.

Coley A, Parisi K, Masciantonio R, Hoeck J, Casey J, Murphy V . The most polymorphic residue on Plasmodium falciparum apical membrane antigen 1 determines binding of an invasion-inhibitory antibody. Infect Immun. 2006; 74(5):2628-36. PMC: 1459722. DOI: 10.1128/IAI.74.5.2628-2636.2006. View

15.

Malkin E, Diemert D, McArthur J, Perreault J, Miles A, Giersing B . Phase 1 clinical trial of apical membrane antigen 1: an asexual blood-stage vaccine for Plasmodium falciparum malaria. Infect Immun. 2005; 73(6):3677-85. PMC: 1111886. DOI: 10.1128/IAI.73.6.3677-3685.2005. View

16.

Triglia T, HEALER J, Caruana S, Hodder A, Anders R, Crabb B . Apical membrane antigen 1 plays a central role in erythrocyte invasion by Plasmodium species. Mol Microbiol. 2000; 38(4):706-18. DOI: 10.1046/j.1365-2958.2000.02175.x. View

17.

Cortes A, Mellombo M, Mueller I, Benet A, Reeder J, Anders R . Geographical structure of diversity and differences between symptomatic and asymptomatic infections for Plasmodium falciparum vaccine candidate AMA1. Infect Immun. 2003; 71(3):1416-26. PMC: 148836. DOI: 10.1128/IAI.71.3.1416-1426.2003. View

18.

Mital J, Meissner M, Soldati D, Ward G . Conditional expression of Toxoplasma gondii apical membrane antigen-1 (TgAMA1) demonstrates that TgAMA1 plays a critical role in host cell invasion. Mol Biol Cell. 2005; 16(9):4341-9. PMC: 1196342. DOI: 10.1091/mbc.e05-04-0281. View

19.

Collins W, Pye D, Crewther P, Vandenberg K, Galland G, SULZER A . Protective immunity induced in squirrel monkeys with recombinant apical membrane antigen-1 of Plasmodium fragile. Am J Trop Med Hyg. 1994; 51(6):711-9. DOI: 10.4269/ajtmh.1994.51.711. View

20.

Pizarro J, Vulliez-Le Normand B, Chesne-Seck M, Collins C, Withers-Martinez C, Hackett F . Crystal structure of the malaria vaccine candidate apical membrane antigen 1. Science. 2005; 308(5720):408-11. DOI: 10.1126/science.1107449. View